Publications by authors named "Andrew Scheibe"

Claim this Profile
A
Addressing policy barriers to scaling up needle and syringe programmes: a global call to action.
Guillaume Fontaine, Emma Day, Niklas Luhmann, Annie Madden, Keith Sabin, Andrew Scheibe

Lancet Glob Health· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016-2017.
Nkosenhle L Ndlovu, Andrew Scheibe, Harry Hausler, Mark W Sonderup, C Wendy Spearman

PLoS One· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cascading Training Model to Promote Screening, Brief Intervention, and Referral to Treatment Across South Africa: Rollout in an HIV Service Organization.
Kira DiClemente-Bosco, Caroline Kuo, Goodman Sibeko, Shaheema Allie, Timothy Souza, Andrew Scheibe

Implement Res Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
South African harm reduction guideline for chemsex.
Andrew Scheibe, Yolaan Andrews, Ben Brown, Naeem Cassim, Thato Chidarikire

South Afr J HIV Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of women on opioid substitution therapy in primary healthcare in Tshwane (South Africa): a retrospective observational study.
Daniela S Goeieman, Robert Mash, Natasha R Gloeck, Andrew Scheibe

BJGP Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South Africa.
Andrew Scheibe, Joel Steingo, Gaynor Grace, Helen Savva, Mark Sonderup

Int J Drug Policy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug use patterns and health problems among people who use drugs in Guinea-Bissau (2022): A cross-sectional survey using respondent-driven sampling.
Andrew Scheibe, Andreia Teixeira, Mamadu Aliu Djaló, Miriam Nascimento Pereira, Kátia Ribeiro Barreto

Int J Drug Policy· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort study.
Adelina Artenie, Rachel Perry, Memory Mahaso, Thenjiwe Jankie, Anna L McNaughton, Andrew Scheibe

Lancet HIV· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating client functioning in a harm reduction program in South Africa: insights from a tool derived from the International Classification of Functioning, Disability and Health.
Michelle N S Janse van Rensburg, Daleen Casteleijn, Andrew Scheibe

Front Rehabil Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'I went for rehab many times and it never worked, but the harm reduction process has given me renewed hope'. Perceptions on the effectiveness of harm reduction and community-based opioid substitution therapy.
Tichaenzana Nyashanu, Andrew Scheibe, Maretha Visser

Health Promot J Austr· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-cigarettes and harm reduction: a view from sub-Saharan Africa.
Catherine O Egbe, Arshima Khan, Andrew Scheibe, Olalekan A Ayo-Yusuf

Tob Control· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Alison D Marshall, Alex R Willing, Abe Kairouz, Evan B Cunningham, Alice Wheeler, Andrew Scheibe

Lancet Gastroenterol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002-2017.
Kennedy Kipkoech Mutai, Jack Stone, Andrew Scheibe, Hannah Fraser, Leigh F Johnson

Int J Drug Policy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing cardiac safety among clients receiving methadone as part of opioid agonist maintenance therapy (OAMT) in Durban, South Africa.
Dorcas Rosaley Prakaschandra, Andrew Scheibe, Monique Marks, Datshana Prakesh Naidoo

J Addict Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study.
Mpho Tlali, Andrew Scheibe, Yann Ruffieux, Morna Cornell, Anja E Wettstein

Int J Drug Policy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting.
Urvisha Bhoora, Natasha R Gloeck, Andrew Scheibe

Afr J Prim Health Care Fam Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of low-income and middle-income country prisons in eliminating hepatitis C.
Matthew J Akiyama, Nadine Kronfli, Joaquin Cabezas, Yumi Sheehan, Andrew Scheibe

Lancet Public Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Michael Wilson, Amanda Brumwell, M J Stowe, Shaun Shelly, Andrew Scheibe

Harm Reduct J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa.
Nishi Prabdial-Sing, Lucinda Gaelejwe, Lillian Makhathini, Jayendrie Thaver, Morubula Jack Manamela, Andrew Scheibe

Health Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Southern African HIV Clinicians Society guidelines for harm reduction.
Andrew Scheibe, Goodman Sibeko, Shaun Shelly, Theresa Rossouw, Vincent Zishiri

South Afr J HIV Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
Andrew Scheibe, Katherine Young, Anna Versfeld, C Wendy Spearman, Mark W Sonderup

BMC Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdown.
Tessa S Marcus, Jan Heese, Andrew Scheibe, Shaun Shelly, Sasha X Lalla

Harm Reduct J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
Anna Versfeld, Angela McBride, Andrew Scheibe, C Wendy Spearman

Harm Reduct J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
Andrew Scheibe, Shaun Shelly, Johannes Hugo, Matilda Mohale, Sasha Lalla

Afr J Prim Health Care Fam Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion.
Monique Marks, Andrew Scheibe, Shaun Shelly

Harm Reduct J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis